All In Biotech

Free tool

FAERS Monitor: Nexiclon Xr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022500 or its brand name (Nexiclon Xr, Clonidine). Reports on generic versions are filed under their own applications.

Reports

51,063

Serious

35,861

70% of reports

Hospitalization

18,436

Death reported

6,117

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,905
  • pain3,144
  • nausea3,068
  • fatigue3,049
  • off label use3,046
  • headache2,949
  • hypertension2,704
  • dyspnoea2,376
  • diarrhoea2,359
  • vomiting2,146
  • chronic kidney disease2,116
  • dizziness1,934
  • renal failure1,920
  • acute kidney injury1,861
  • blood pressure increased1,684

Reports by year received

View as table
YearReports
2004509
2005983
2006964
2007945
2008929
20091,298
20101,558
20111,792
20121,951
20131,768
20142,447
20152,894
20163,175
20173,151
20183,590
20193,735
20203,082
20212,798
20222,534
20232,813
20242,943
20252,899
20262,305

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,003,096 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal2,11611.811.320,337
renal failureSignal1,9206.05.87,981
hypertensionSignal2,7045.35.19,440
acute kidney injurySignal1,8615.14.86,026
blood pressure increasedSignal1,6844.64.44,685
painSignal3,1442.12.01,890
headache2,9491.91.91,381
vomiting2,1461.91.8906
dyspnoea2,3761.71.7751
fatigue3,0491.61.6739
dizziness1,9341.61.5443
nausea3,0681.61.5712
diarrhoea2,3591.51.4413
off label use3,0461.41.4416
drug ineffective3,9051.21.2166

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.